C.D. Furberg

951 total citations
17 papers, 690 citations indexed

About

C.D. Furberg is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, C.D. Furberg has authored 17 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in C.D. Furberg's work include Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Cardiovascular Disease and Adiposity (3 papers). C.D. Furberg is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Cardiovascular Disease and Adiposity (3 papers). C.D. Furberg collaborates with scholars based in United States, New Zealand and Netherlands. C.D. Furberg's co-authors include J. Fröhlich, Anthony Keech, Ingmar Jungner, Göran Walldius, John R. Crouse, Grethe S. Tell, L Lundkvist, Kurt Svärdsudd, C. Ericson and G. Dahlén and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

C.D. Furberg

16 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.D. Furberg United States	8	356	338	231	118	108	17	690
Jennifer Baker Australia	6	249 0.7×	478 1.4×	147 0.6×	120 1.0×	101 0.9×	7	773
Э. Г. Волкова Russia	3	303 0.9×	288 0.9×	199 0.9×	89 0.8×	88 0.8×	7	627
Paolo Pauciullo Italy	14	212 0.6×	302 0.9×	281 1.2×	64 0.5×	66 0.6×	34	624
P Schaffer France	13	270 0.8×	313 0.9×	123 0.5×	137 1.2×	111 1.0×	34	887
M. Ishola United Kingdom	11	504 1.4×	507 1.5×	188 0.8×	87 0.7×	145 1.3×	16	850
F. Heller Belgium	15	202 0.6×	348 1.0×	98 0.4×	156 1.3×	67 0.6×	51	709
Michael J. Blaha United States	18	349 1.0×	521 1.5×	210 0.9×	82 0.7×	128 1.2×	44	881
D. P. Mikhailidis United Kingdom	12	376 1.1×	457 1.4×	227 1.0×	148 1.3×	116 1.1×	22	896
Naresh Ranjith South Africa	15	155 0.4×	224 0.7×	377 1.6×	114 1.0×	62 0.6×	34	681
M van Linde-Sibenius Trip Netherlands	8	480 1.3×	706 2.1×	401 1.7×	94 0.8×	216 2.0×	8	1.2k

Countries citing papers authored by C.D. Furberg

Since Specialization

Citations

This map shows the geographic impact of C.D. Furberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.D. Furberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.D. Furberg more than expected).

Fields of papers citing papers by C.D. Furberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.D. Furberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.D. Furberg. The network helps show where C.D. Furberg may publish in the future.

Co-authorship network of co-authors of C.D. Furberg

This figure shows the co-authorship network connecting the top 25 collaborators of C.D. Furberg. A scholar is included among the top collaborators of C.D. Furberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.D. Furberg. C.D. Furberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Volpe, Massimo, Michael H. Alderman, C.D. Furberg, et al.. (2004). . American Journal of Hypertension. 17(11). 1068–1074. 47 indexed citations

Sniderman, Allan D., C.D. Furberg, Anthony Keech, et al.. (2004). Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Clínica e Investigación en Arteriosclerosis. 16(1). 38–38. 5 indexed citations

Furberg, C.D., et al.. (2003). Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. The Lancet. 361(9359). 777–780. 360 indexed citations

Furberg, C.D., et al.. (2003). Lipoproteins and cardiovascular risk. The Lancet. 361(9373). 1989–1989. 1 indexed citations

Heckbert, Susan R., Robert C. Kaplan, Noel S. Weiss, et al.. (2001). Risk of Recurrent Coronary Events in Relation to Use and Recent Initiation of Postmenopausal Hormone Therapy. Archives of Internal Medicine. 161(14). 1709–1709. 65 indexed citations

Psaty, Bruce M., C.D. Furberg, M. Pahor, Michael H. Alderman, & Lewis H. Kuller. (2000). National Guidelines, Clinical Trials, and Quality of Evidence. Archives of Internal Medicine. 160(17). 2577–2577. 8 indexed citations

Byington, Robert P., et al.. (1998). Lipid lowering therapy in CAD patients at Academic Medical Centers: undertreatment and evidence of a gender gap. Journal of the American College of Cardiology. 31. 186–186. 3 indexed citations

Furberg, C.D. & Bruce M. Psaty. (1996). Should calcium antagonists be first line drugs in hypertension?. ACC Current Journal Review. 5(4). 58–59. 9 indexed citations

Byington, Robert P., Gregory W. Evans, William B. Applegate, & C.D. Furberg. (1994). Predictors of carotid atherosclerosis progression. Atherosclerosis. 109(1-2). 15–15. 2 indexed citations

10.

Furberg, C.D.. (1994). Challenges to the Funding of Prevention Research. Preventive Medicine. 23(5). 599–601. 7 indexed citations

11.

Espeland, Mark A., et al.. (1994). Relative impact of lovastatin and estrogen replacement therapy on progression of intimal-medial thickness in the carotid arteries. Atherosclerosis. 109(1-2). 154–154. 2 indexed citations

12.

Furberg, C.D., Helena Hoen, Mark A. Espeland, William B. Applegate, & Birgitte H. Bendixen. (1994). Effect of lovastatin on early carotid atherosclerosis in women. Atherosclerosis. 109(1-2). 158–158. 1 indexed citations

13.

Furberg, C.D.. (1994). Lovastatin, early carotid atherosclerosis and cardiovascular events: the results of ACAPS. Atherosclerosis. 109(1-2). 259–259. 1 indexed citations

14.

Levy, R. I., David H. Blankenhorn, David J. Gordon, et al.. (1989). AHA Conference Report on Cholesterol. Intervention studies.. Circulation. 80(3). 739–743. 7 indexed citations

15.

Tell, Grethe S., John R. Crouse, & C.D. Furberg. (1988). Relation between blood lipids, lipoproteins, and cerebrovascular atherosclerosis. A review.. Stroke. 19(4). 423–430. 108 indexed citations

16.

Furberg, C.D., et al.. (1975). [The long QT-syndrome].. PubMed. 72(47). 4620–5. 1 indexed citations

17.

Dahlén, G., C. Ericson, C.D. Furberg, L Lundkvist, & Kurt Svärdsudd. (1972). Studies on an extra pre-beta lipoprotein fraction.. PubMed. 531. 1–29. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact